GlucoSet is a company developing a tool for continuous glucose monitoring in intensive care units. Its sensor is a biosensor with a hydrogel matrix incorporated with 3-phenylboronic acid. The gel contracts at rising glucose concentrations as a consequence of glucose-induced cross-binding of phenylboronic molecules.